Abbreviations
3TC |
lamivudine |
ABC |
abacavir |
ART |
antiretroviral therapy |
ARV |
antiretroviral |
AUC24 h |
24-hour area under the concentration–time curve |
C24 h |
24-hour plasma concentration |
CL |
clearance |
CYP |
cytochrome 450 |
DTG |
dolutegravir |
EFV |
efavirenz |
EMA |
European Medicines Agency |
EU |
European Union |
FDA |
United States Food and Drug Administration |
FTC |
emtricitabine |
HBV |
hepatitis B virus |
HCV |
hepatitis C virus |
IMPAACT
|
International Maternal Pediatric Adolescent AIDS Clinical Trials |
LPV/r |
lopinavir/ritonavir |
NRTI |
nucleoside reverse-transcriptase inhibitor |
PANNA |
Pharmacokinetics of Newly Developed Antiretroviral Agents in HIV-Infected Pregnant Women |
PENPACT |
PENTA 9/PACTG 390 |
PENTA |
Paediatric European Network for Treatment of AIDS |
PEPFAR |
United States President’s Emergency Plan for AIDS Relief |
TAF |
tenofovir alafenamide |
TB |
tuberculosis |
TDF |
tenofovir disoproxil fumarate |
UGT |
uridine diphosphate-glucuronosyltransferase |
UNICEF |
United Nations Children’s Fund |
WT |
body weight |
Recognition
This toolkit is formally recognised for its quality and content by the following organisations and institutions:
For further information please contact: training@theglobalhealthnetwork.org